Get the Stockscreener App
0.237
4.90%
-0.0122
ELITE PHARMS INC Stock (ELTP) Forecast
The ELITE PHARMS INC (ELTP) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $0.2074, representing a -12.49% decrease from the current price of $0.237. The highest analyst price target is $0.256, and the lowest is $0.1588.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month ELTP Price Target
Average 0.1473
(-37.83% Downside)
Is ELITE PHARMS INC (ELTP) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 40.34 | Neutral |
| STOCH(9,6) | 55.23 | Neutral |
| STOCHRSI(14) | 31.84 | Neutral |
| MACD(12,26) | -0.0041 | Buy |
| ADX(14) | 31.25 | Sell |
| William %R | -65.67 | Neutral |
| CCI(14) | -76.71 | Neutral |
Buy: 1
Sell: 1
Neutral: 5
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
0.2485
Sell
|
0.2474
Sell
|
| MA20 |
0.2468
Sell
|
0.2494
Sell
|
| MA50 |
0.2591
Sell
|
0.2676
Sell
|
| MA100 |
0.313
Sell
|
0.3012
Sell
|
| MA200 |
0.3515
Sell
|
0.3648
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, ELTP could be considered a Strong Sell, with 17 technical analysis indicators signaling 1 Buy signals, 11 signaling Sell signals and 5 Neutral signals. This might not be a good time to consider opening new positions on ELTP, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 40.34 indicates that ELTP is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 55.23 indicates that ELTP is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 31.84 indicates that ELTP is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 31.25 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -76.71 indicates that ELTP is still oversold but not to an extreme extent.
Long-term ELTP price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about ELITE PHARMS INC financial reports and earnings history, ELITE PHARMS INC (ELTP) stock could reach $0.4975 by 2030, $2.7362 by 2040 and $4.8322 by 2050. See the projected annual prices until 2050 of the ELITE PHARMS INC stock below:
- ELITE PHARMS INC (ELTP) is expected to reach an average price of $1.4924 in 2035, with a high prediction of $1.6407 and a low estimate of $1.5387. This indicates an $529.72% rise from the last recorded price of $0.237.
- ELITE PHARMS INC (ELTP) stock is projected to chart a bullish course in 2040, with an average price target of $2.5652, representing an $982.35% surge from its current level. The forecast ranges from a conservative $2.5792 to a sky-high $2.7362.
- Our analysts predict ELITE PHARMS INC (ELTP) to jump 1,392% by 2045, soaring from $3.5501 to an average price of $3.5351, potentially reaching $3.8066. While $3.5501 is the low estimate, the potential upside is significant.
- ELITE PHARMS INC (ELTP) stock is expected to climb by 2050, reaching an average of $4.4559, a $1,780% jump from its current level. However, a wide range of estimates exists, with high and low targets of $4.8322 and $4.501, respectively, highlighting the market's uncertainty.
ELITE PHARMS INC Stock (ELTP) Year by Year Forecast
ELITE PHARMS INC Stock (ELTP) Price Forecast for 2026
The predicted value for ELITE PHARMS INC (ELTP) in 2026 is set at an average of $0.3366. Estimates vary from a peak of $0.5143 to a trough of $0.1588, indicating an +42.01% surge from the present price of $0.237.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| November, 2026 | $0.1897 | $0.1588 | $0.256 | -19.94% |
| December, 2026 | $0.2672 | $0.1611 | $0.2822 | +12.73% |
ELITE PHARMS INC Stock (ELTP) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for ELITE PHARMS INC (ELTP) is $0.1245, with a high forecast of $0.2365 and a low forecast of $0.0125. This indicates an -47.46% decrease from the last price of $0.237.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $0.1096 | $0.0996 | $0.2365 | -53.76% |
| February, 2027 | $0.127 | $0.0825 | $0.1413 | -46.40% |
| March, 2027 | $0.0955 | $0.0195 | $0.1414 | -59.70% |
| April, 2027 | $0.0652 | $0.0125 | $0.1474 | -72.47% |
| May, 2027 | $0.0679 | $0.038 | $0.0861 | -71.34% |
| June, 2027 | $0.047 | $0.0406 | $0.0894 | -80.18% |
| July, 2027 | $0.0684 | $0.0493 | $0.0784 | -71.14% |
| August, 2027 | $0.1398 | $0.0612 | $0.1715 | -41.02% |
| September, 2027 | $0.1504 | $0.0944 | $0.199 | -36.56% |
| October, 2027 | $0.0895 | $0.0516 | $0.1615 | -62.22% |
| November, 2027 | $0.0643 | $0.0423 | $0.1079 | -72.85% |
| December, 2027 | $0.0474 | $0.0348 | $0.0744 | -79.99% |
ELITE PHARMS INC Stock (ELTP) Price Forecast for 2028
In 2028, ELITE PHARMS INC (ELTP) is projected to reach an average price of $0.1491, with a high projection of $0.2621 and a low estimate of $0.0361. This indicates an -37.08% fall from the last price of $0.237.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $0.1935 | $0.0361 | $0.1935 | -18.35% |
| February, 2028 | $0.2355 | $0.2366 | $0.2141 | -0.62% |
| March, 2028 | $0.1407 | $0.2047 | $0.2018 | -40.64% |
| April, 2028 | $0.2808 | $0.2845 | $0.2508 | +18.49% |
| May, 2028 | $0.2522 | $0.2779 | $0.2621 | +6.43% |
| June, 2028 | $0.2557 | $0.267 | $0.2557 | +7.88% |
| July, 2028 | $0.2717 | $0.281 | $0.2576 | +14.64% |
| August, 2028 | $0.244 | $0.2714 | $0.2508 | +2.97% |
| September, 2028 | $0.2476 | $0.2359 | $0.2252 | +4.46% |
| October, 2028 | $0.2015 | $0.2095 | $0.2221 | -14.98% |
| November, 2028 | $0.1155 | $0.1606 | $0.1381 | -51.25% |
| December, 2028 | $0.0875 | $0.1141 | $0.1025 | -63.07% |
ELITE PHARMS INC Stock (ELTP) Price Forecast for 2029
The 2029 price forecast for ELITE PHARMS INC Stock (ELTP) is $0.3728 on average, with a high prediction of $0.6481 and a low estimate of $0.0974. This represents an +57.29% increase from the previous price of $0.237.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $0.1372 | $0.1001 | $0.1082 | -42.11% |
| February, 2029 | $0.1343 | $0.1343 | $0.1293 | -43.32% |
| March, 2029 | $0.1338 | $0.1399 | $0.1286 | -43.54% |
| April, 2029 | $0.6362 | $0.0974 | $0.6362 | +168.44% |
| May, 2029 | $0.6608 | $0.6739 | $0.6394 | +178.82% |
| June, 2029 | $0.5485 | $0.6125 | $0.6227 | +131.44% |
| July, 2029 | $0.6726 | $0.6793 | $0.6481 | +183.82% |
| August, 2029 | $0.6209 | $0.6508 | $0.6309 | +161.96% |
| September, 2029 | $0.6069 | $0.6313 | $0.6069 | +156.06% |
| October, 2029 | $0.6011 | $0.6104 | $0.5914 | +153.63% |
| November, 2029 | $0.556 | $0.5859 | $0.5721 | +134.60% |
| December, 2029 | $0.522 | $0.531 | $0.5328 | +120.27% |
ELITE PHARMS INC Stock (ELTP) Price Forecast for 2030
ELITE PHARMS INC Stock (ELTP) is expected to reach an average price of $0.6701 in 2030, with a high forecast of $1.0789 and a low forecast of $0.2612. This signifies an +182.72% surge from the last price of $0.237.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $0.4742 | $0.4822 | $0.4975 | +100.10% |
| February, 2030 | $0.3709 | $0.416 | $0.4021 | +56.48% |
| March, 2030 | $0.3254 | $0.352 | $0.3491 | +37.30% |
| April, 2030 | $0.3533 | $0.3259 | $0.3243 | +49.07% |
| May, 2030 | $0.333 | $0.3416 | $0.3353 | +40.51% |
| June, 2030 | $0.3151 | $0.3266 | $0.3229 | +32.93% |
| July, 2030 | $1.0789 | $0.2612 | $1.0789 | +355.23% |
| August, 2030 | $1.0861 | $1.1035 | $1.0685 | +358.26% |
| September, 2030 | $1.0969 | $1.0204 | $1.0436 | +362.84% |
| October, 2030 | $1.0587 | $1.069 | $1.0465 | +346.71% |
| November, 2030 | $0.9895 | $1.0237 | $1.0126 | +317.50% |
| December, 2030 | $0.9473 | $0.9762 | $0.967 | +299.71% |
Cap:
|
Volume (24h):